SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 366 participants.
Also called NCT02439749
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 366 participants
- Sponsor
- Registry
-
NCT02439749
-
- Other papers using this trial's data
- Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation
- Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension
- Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
- Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Canada, Germany, Greece, Ireland, Japan, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02439749. Randomized; single masking; primary purpose treatment. Start 2015-06 (actual); primary completion 2020-04-30 (actual). Results posted on 2021-05-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study
- Condition
- Hypertension
- Condition
- Vascular Diseases
- Condition
- Cardiovascular Diseases
- Intervention (Device)
- Symplicity Spyral™ multi-electrode renal denervation system
- Intervention (Procedure)
- Sham Procedure
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct02439749- Content hash
58eb0885a1f4d98450202302035ab700fe5f20568bbcad5b68c28c4ddee4765e